IDEXX Laboratories Inc. closed 27.51% short of its 52-week high of $583.39, which the company reached on March 1st.

Shares of IDEXX Laboratories Inc. IDXX slipped 2.18% to $419.26 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.00% to ...

IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...

ST Germain D J Co. Inc. grew its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 517.2% in the 4th quarter, ...

While IDEXX Laboratories, Inc. (NASDAQ:IDXX) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 21% in the last quarter.

Signal Advisors Wealth LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 25.7% in the fourth ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An announcement from Idexx ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neumora Therapeutics, Inc. (NMRA – Research Report) and ...

IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes products mainly for the companion animal veterinary, livestock and poultry ...